메뉴 건너뛰기




Volumn 14, Issue 12, 2008, Pages 1678-1682

Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease

Author keywords

Allopurinol; Inflammatory bowel disease; Pediatric; Thiopurine metabolism

Indexed keywords

6 METHYL MERCAPTOPURINE; ALLOPURINOL; AMINOSALICYLIC ACID; AMINOTRANSFERASE; AZATHIOPRINE; DRUG METABOLITE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; PREDNISONE; TIOGUANINE; UNCLASSIFIED DRUG; 6-METHYLTHIOPURINE; ANTIMETABOLITE; DRUG DERIVATIVE; METHYLMERCAPTOPURINE;

EID: 52149089035     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20522     Document Type: Article
Times cited : (43)

References (17)
  • 1
    • 4444224484 scopus 로고    scopus 로고
    • Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety
    • Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenteroll Hepatol. 2004;2:731-743.
    • (2004) Clin Gastroenteroll Hepatol , vol.2 , pp. 731-743
    • Dubinsky, M.C.1
  • 2
    • 33748555869 scopus 로고    scopus 로고
    • Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center
    • Banerjee S. Bishop WP. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center. J Pediatr Gastroenterol Nutr. 2006;43:353-356.
    • (2006) J Pediatr Gastroenterol Nutr , vol.43 , pp. 353-356
    • Banerjee, S.1    Bishop, W.P.2
  • 3
    • 0029134702 scopus 로고
    • Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
    • Pearson DC, May GR, Fick GH, et. al. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med. 1995; 123:1321-142.
    • (1995) Ann Intern Med , vol.123 , pp. 1321-2142
    • Pearson, D.C.1    May, G.R.2    Fick, G.H.3    et., al.4
  • 4
    • 0034023321 scopus 로고    scopus 로고
    • A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: Origins at the Mount Sinai Hospital
    • Korelitz BI. A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at the Mount Sinai Hospital. Mt Sinai J Med. 2000;67:214-226.
    • (2000) Mt Sinai J Med , vol.67 , pp. 214-226
    • Korelitz, B.I.1
  • 6
    • 0019782219 scopus 로고    scopus 로고
    • Theodor E, Niv Y, Bat L. Imuran in the treatment of ulcerative colitis. Am J Gastroenterol. 1981;76:262-266.
    • Theodor E, Niv Y, Bat L. Imuran in the treatment of ulcerative colitis. Am J Gastroenterol. 1981;76:262-266.
  • 7
    • 0034036355 scopus 로고    scopus 로고
    • Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease
    • Kader HA, Wenner WJ Jr, Telega GW, et al. Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease. J Clin Gastroenterol. 2000;30:409-413.
    • (2000) J Clin Gastroenterol , vol.30 , pp. 409-413
    • Kader, H.A.1    Wenner Jr, W.J.2    Telega, G.W.3
  • 8
    • 0037246773 scopus 로고    scopus 로고
    • Mercaptopurine metabolite results in clinical gastroenterology practice
    • Bloomfeld RS, Onken JE. Mercaptopurine metabolite results in clinical gastroenterology practice. Aliment Pharmacol Ther. 2003;17:69-73.
    • (2003) Aliment Pharmacol Ther , vol.17 , pp. 69-73
    • Bloomfeld, R.S.1    Onken, J.E.2
  • 9
    • 0034067784 scopus 로고    scopus 로고
    • Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
    • Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705-713.
    • (2000) Gastroenterology , vol.118 , pp. 705-713
    • Dubinsky, M.C.1    Lamothe, S.2    Yang, H.Y.3
  • 10
    • 33646011261 scopus 로고    scopus 로고
    • Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
    • Osterman MT, Kundu R, Lichtenstein GR, et al. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology. 2006;130:1047-1053.
    • (2006) Gastroenterology , vol.130 , pp. 1047-1053
    • Osterman, M.T.1    Kundu, R.2    Lichtenstein, G.R.3
  • 11
    • 0037237923 scopus 로고    scopus 로고
    • Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD
    • Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord. 2003;3(suppl 1):S30-38.
    • (2003) Rev Gastroenterol Disord , vol.3 , Issue.SUPPL. 1
    • Seidman, E.G.1
  • 12
    • 33846820178 scopus 로고    scopus 로고
    • Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine
    • Sparrow MP, Hande SA, Friedman S, et al. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol. 2007;5: 209-214.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 209-214
    • Sparrow, M.P.1    Hande, S.A.2    Friedman, S.3
  • 13
    • 24344480999 scopus 로고    scopus 로고
    • Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine
    • Sparrow MP, Hande SA, Friedman S, et al. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther. 2005;22:441-446.
    • (2005) Aliment Pharmacol Ther , vol.22 , pp. 441-446
    • Sparrow, M.P.1    Hande, S.A.2    Friedman, S.3
  • 14
    • 0033794050 scopus 로고    scopus 로고
    • Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine
    • Bowen D, Selby W. Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine. Dig Dis Sci. 2000;45:1810-1813.
    • (2000) Dig Dis Sci , vol.45 , pp. 1810-1813
    • Bowen, D.1    Selby, W.2
  • 15
    • 0027161587 scopus 로고
    • Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen
    • Chocair P, Duley J, Simmonds HA, et al. Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen. Lancet. 1993;342:83-84.
    • (1993) Lancet , vol.342 , pp. 83-84
    • Chocair, P.1    Duley, J.2    Simmonds, H.A.3
  • 16
    • 28844490574 scopus 로고    scopus 로고
    • Observations on the use of allopurinol in combination with azathioprine or mercaptopurine
    • Duley JA, Chocair PR, Florin TH. Observations on the use of allopurinol in combination with azathioprine or mercaptopurine. Aliment Pharmacol Ther. 2005;22:1161-1162
    • (2005) Aliment Pharmacol Ther , vol.22 , pp. 1161-1162
    • Duley, J.A.1    Chocair, P.R.2    Florin, T.H.3
  • 17
    • 61649106169 scopus 로고    scopus 로고
    • Allopurinol. In: DRUGDEX Evaluations [intranet database]. Version 5.1. Greenwood Village, CO: Thomson Healthcare. Accessed March 24, 2008.
    • Allopurinol. In: DRUGDEX Evaluations [intranet database]. Version 5.1. Greenwood Village, CO: Thomson Healthcare. Accessed March 24, 2008.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.